ArticleFrontiers in molecular biosciences2026
Expanding the genetic code: phage-driven evolution of pyrrolysyl-synthetase for site-specific incorporation of synthetic phenylalanine and tyrosine derivatives.
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genetic Code Expansion Enables Oriented, Site-Specific Conjugation of DARPins to Lipid Nanoparticles for Selective mRNA Delivery to CD8International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pyrrolysyl-tRNA synthetase (PylRS) is a key enzyme for the site-specific incorporation of non-canonical amino acids (ncAAs) into proteins. However, its native form has a limited substrate scope. This study aimed to evolve PylRS from Methods: We used phage-assisted non-continuous evolution (PANCE) to generate a library of PylRS variants under selective pressure for the target ncAAs. Evolved variants were sequenced to identify mutations. Their aminoacylation efficiency and specificity were quantitatively assessed using fluorescence-based incorporation assays and mass spectrometry. Results: Sequencing revealed a polymorphic population of mutations, with a significant cluster located within the enzyme's amino acid binding pocket. Several evolved variants showed an orders-of-magnitude increase in the efficiency of incorporating their target ncAAs compared to the wild-type enzyme. Discussion/Conclusion: Our findings confirm that PANCE is a highly effective method for engineering PylRS variants with strong and specific activity towards desired non-canonical amino acids. The identified mutations, particularly those in the binding pocket, provide a basis for understanding and further optimising substrate specificity in synthetic biology applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.